Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

107 results
Display

Good Agreement between an Interferon Gamma Release Assay and Tuberculin Skin Tests in Testing for Latent Tuberculosis Infection among HIV-Infected Patients in Indonesia

Reviono R, Saptawati , Redhono D, Suryawati

BACKGROUND: Latent tuberculosis infection is a condition where there is a persistent immune response to Mycobacterium tuberculosis without clinical manifestations of tuberculosis. Currently, there is no gold standard to diagnose...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Performance of the Agility System for Interferon Gamma Release Assay Using QuantiFERON TB Gold In-Tube Assay

Seok K, Shin S

BACKGROUND: As stated in ‘The Action Strategy for Tuberculosis-Free Korea,’ last March, high-throughput, large-scale analytical instruments for interferon gamma release assays (IGRA) are demanded by many clinical laboratories using the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Depletion of MicroRNA-373 Represses the Replication of Hepatitis C Virus via Activation of Type 1 Interferon Response by Targeting IRF5

Gong W, Guo X, Zhang Y

PURPOSE: Hepatitis C virus (HCV) poses a risk of chronic liver disease and threatens a significant number of people worldwide. MicroRNAs (miRNAs) are linked to the regulation of hepatocarcinogenesis. Although...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical implication of serum uric acid level in pegylated interferon and ribavirin combination therapy for chronic hepatitis C infection

Oh IS, Won JW, Kim HJ, Lee HW

BACKGROUND/AIMS: Combined treatment of pegylated interferon-α (PEG-IFN) and ribavirin (RBV) has long been accepted as the standard treatment for chronic hepatitis C virus (HCV) infection. Many predictive factors for treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Recurrent Myxomatous Corneal Degeneration Treated by Interferon Alpha-2b

Park YM, Ahn M, Kang WS, You IC

PURPOSE: To report a case of recurrent myxomatous corneal degeneration after pterygectomy. CASE SUMMARY: A 65-year-old man with a history of abdominal keloid was referred to our hospital for assessment of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparing tuberculin skin test and interferon γ release assay (T-SPOT.TB) to diagnose latent tuberculosis infection in household contacts

Lee HW, Lee YJ, Kim SJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH

BACKGROUND/AIMS: The tuberculin skin test (TST) and interferon γ release assay are currently used as diagnostic tools to detect latent tuberculosis (TB) infection; however, there are inconsistencies about the degree...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Systemic and Local Interferon Beta-1a on Epidural Fibrosis

Taşkapılıoğlu MO, Işık S, Doğan S, Özgün G, Ocakoğlu , Uğraş N

STUDY DESIGN: Level 1 randomized controlled study. PURPOSE: To investigate the effects of systemic and local interferon-beta-1a (IFN-β-1a) on prevention of epidural fibrosis using histopathological parameters. OVERVIEW OF LITERATURE: Epidural fibrosis involves...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C

Song JS, Sohn JH, Jeong JY, Min JH, Choi WS, Kim OZ, Pyo JY

Pegylated interferon alpha (PEG-IFN-α) is widely used to treat chronic hepatitis C in combination with ribavirin. Many adverse effects of PEG-IFN-α, such as hematologic, psychologic, dermatologic, immunologic, and other abnormalities,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cutaneous Ulceration after Injection of Interferon Alpha in a Melanoma Patient

Seo J, Lee YI, Lee JW, Chung KY

  • KMID: 2162230
  • Korean J Dermatol.
  • 2016 Mar;54(3):220-221.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reduction of Disease Activity in Patient with Relapsing-Remitting Multiple Sclerosis after Switching to Teriflunomide from Interferon Beta

Shin KS, Park JG, Park MS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Study on the Anxiety of the Chronic Viral Hepatitis Patients Receiving Pegylated Interferon Therapy

Kim JH, Choi HY, Kim TH, Kim SI

OBJECTIVES: The aim of this study was to clarify anxiety symptoms associated with the pegylated interferon (PEG-IFN) treatment and to determine which factors are associated with these anxiety symptoms. METHODS: The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reactive Oxygen Species, Interferon and Antiviral Innate Immune Response in Nasal Mucosa

Hong SN, Kim HJ

The regulated production of reactive oxygen species (ROS) has been considered a unique property of phagocytic cells which use this ROS system to induce innate defense system that enables it...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute Pancreatitis Associated with Pegylated Interferon alpha-2b and Ribavirin Treatment of Chronic Hepatitis C

Ahn S, Ku YH, Ha SY, Lee R, Koo C

Acute pancreatitis is an uncommon side effect of pegylated interferon (PEG-IFN) alpha-2b and ribavirin (RBV) combination therapy. In South Korea, There is a no report of acute pancreatitis associated PEG-IFN...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Polymyositis after Pegylated Interferon Therapy for Hepatitis C

Kim SN, Han SM, Park JH, Kim JY, Park JH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Can Non-invasive Fibrosis Assessment Predict Sustained Virological Response to Telaprevir with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients?

Kim MN, Kim JH, Kim SU

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Flare Up Reaction During Provocation Test to Glatiramer Acetate in a Patient With Allergy to Interferon Beta1a

Minciullo , Calapai G, Gangemi S

Glatiramer acetate (GA) is a synthetic amino acid polymer, used for relapsing-remitting multiple sclerosis. The most common adverse effect of GA is a skin reaction at the injection site with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comments to "Alopecia Areata in a Patient Treated with Interferon Alpha-2a for Chronic Hepatitis B"

Yoon TY

  • KMID: 2246354
  • Korean J Dermatol.
  • 2014 Jul;52(7):523-524.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
DICAM-mediated Inhibition of Type 1 Interferon System during Macrophage Differentiation of THP-1 Cells

Kim BY, Park I, Jung YK, Han MS, Kim GW, Han SW

OBJECTIVE: We have previously shown that DICAM inhibits LPS-mediated macrophage differentiation. However, less is known about the exact action mechanisms of DICAM on the macrophage function and differentiation. METHODS: To induce...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Alopecia Areata in a Patient Treated with Interferon Alpha-2a for Chronic Hepatitis B

Kim YS, Lee GM, Bae YI, Park YL, Lee SH

  • KMID: 2246426
  • Korean J Dermatol.
  • 2014 Jan;52(1):40-43.
Recent studies recommend pegylated interferon alpha2a as the first choice treatment for chronic hepatitis B, especially when the patient is negative for HBeAg. Pegylated interferon alpha is known to show...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Extensive Psoriasis Induced by Pegylated Interferon Alfa-2a and Ribavirin in the Treatment of Chronic Hepatitis C

Kim GW, Jwa SW, Song M, Kim HS, Kim BS, Kim MB, Ko HC

A 56-year-old man with chronic hepatitis C was treated with pegylated interferon alfa-2a in combination with ribavirin. However, psoriatic lesions appeared and worsened dramatically during therapy. Because of the extensive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr